Evidence map›Paper›PMID 35091576›Full record

ArticleNature communications2022

Depletion of mitochondrial methionine adenosyltransferase α1 triggers mitochondrial dysfunction in alcohol-associated liver disease.

Lucía Barbier-Torres, Ben Murray, Jin Won Yang, Jiaohong Wang, Michitaka Matsuda, Aaron Robinson, Aleksandra Binek, Wei Fan, David Fernández-Ramos, Fernando Lopitz-Otsoa and 12 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 37 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Posttranslational Regulation of Mammalian Sulfur Amino Acid Metabolism.International journal of molecular sciences · 2025
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Amino acid metabolism in health and disease.Signal transduction and targeted therapy · 2023
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 4 institutions in 3 countries.

Lucía Barbier-TorresKarsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.ORCID http://orcid.org/0000-0002-7675-2888
Ben MurrayKarsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Jin Won YangKarsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.ORCID http://orcid.org/0000-0002-4110-7096
Jiaohong WangKarsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Michitaka MatsudaKarsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Aaron RobinsonSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Aleksandra BinekSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Wei FanKarsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
David Fernández-RamosPrecision Medicine and Metabolism, CIC bioGUNE, BRTA, CIBERehd, Technology Park of Bizkaia, 48160, Derio, Bizkaia, Spain.ORCID http://orcid.org/0000-0003-4651-195X
Fernando Lopitz-OtsoaPrecision Medicine and Metabolism, CIC bioGUNE, BRTA, CIBERehd, Technology Park of Bizkaia, 48160, Derio, Bizkaia, Spain.ORCID http://orcid.org/0000-0001-8452-6939
Maria Luque-UrbanoPrecision Medicine and Metabolism, CIC bioGUNE, BRTA, CIBERehd, Technology Park of Bizkaia, 48160, Derio, Bizkaia, Spain.
Oscar MilletPrecision Medicine and Metabolism, CIC bioGUNE, BRTA, CIBERehd, Technology Park of Bizkaia, 48160, Derio, Bizkaia, Spain.
Nirmala MavilaKarsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Hui PengKarsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.
Komal RamaniKarsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.ORCID http://orcid.org/0000-0002-2387-4603
Roberta GottliebSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.ORCID http://orcid.org/0000-0002-1432-006X
Zhaoli SunDepartment of Surgery and Transplant Biology Research Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Suthat LiangpunsakulDivision of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.
Ekihiro SekiKarsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.ORCID http://orcid.org/0000-0002-9472-6085
Jennifer E Van EykSmidt Heart Institute, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA.ORCID http://orcid.org/0000-0001-9050-148X
Jose M MatoPrecision Medicine and Metabolism, CIC bioGUNE, BRTA, CIBERehd, Technology Park of Bizkaia, 48160, Derio, Bizkaia, Spain.ORCID http://orcid.org/0000-0003-1264-3153
Shelly C LuKarsh Division of Gastroenterology and Hepatology, Cedars-Sinai Medical Center, Los Angeles, CA, 90048, USA. shelly.lu@cshs.org.ORCID http://orcid.org/0000-0003-2128-5407
Cedars-Sinai Medical Center · USCIC bioGUNE · ESJohns Hopkins University · USRichard L. Roudebush VA Medical Center · US

Funding

Methionine Adenosyltransferase α1 and Its Interactome in Alcohol-Associated Liver DiseaseR01AA026759 · NIAAA · CEDARS-SINAI MEDICAL CENTER · PI Shelly Chi-Loo Lu · 2018 to 2026
$3.4M
Role of SAMe in the Progression of Nonalcoholic Fatty Liver DiseaseR01DK123763 · NIDDK · CEDARS-SINAI MEDICAL CENTER · PI LU, SHELLY CHI-LOO · 2020 to 2024
$2.1M
NIAAA NIH HHS R01 AA026759NIDDK NIH HHS R01 DK123763
6 · The paper itself

Abstract

MATα1 catalyzes the synthesis of S-adenosylmethionine, the principal biological methyl donor. Lower MATα1 activity and mitochondrial dysfunction occur in alcohol-associated liver disease. Besides cytosol and nucleus, MATα1 also targets the mitochondria of hepatocytes to regulate their function. Here, we show that mitochondrial MATα1 is selectively depleted in alcohol-associated liver disease through a mechanism that involves the isomerase PIN1 and the kinase CK2. Alcohol activates CK2, which phosphorylates MATα1 at Ser114 facilitating interaction with PIN1, thereby inhibiting its mitochondrial localization. Blocking PIN1-MATα1 interaction increased mitochondrial MATα1 levels and protected against alcohol-induced mitochondrial dysfunction and fat accumulation. Normally, MATα1 interacts with mitochondrial proteins involved in TCA cycle, oxidative phosphorylation, and fatty acid β-oxidation. Preserving mitochondrial MATα1 content correlates with higher methylation and expression of mitochondrial proteins. Our study demonstrates a role of CK2 and PIN1 in reducing mitochondrial MATα1 content leading to mitochondrial dysfunction in alcohol-associated liver disease.

Indexed as

AnimalsBlotting, WesternCasein Kinase IICell LineEthanolFemaleHepatocytesHep G2 CellsHumansIsoenzymesLiverLiver Diseases, AlcoholicMethionine AdenosyltransferaseMiceMice, Inbred C57BLMitochondriaCasein Kinase IIEthanolIsoenzymesMethionine AdenosyltransferaseMitochondrial ProteinsNIMA-Interacting Peptidylprolyl Isomerase

Identifiers

PMID35091576
PMCPMC8799735
OpenAlexW4210541761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.